Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase 3 22Phase 1 20Phase 1/2 9Phase 2/3 2Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 1

Interventions

Standard of Care 176Blood Specimen Collection 135Exercise 121Educational Status 114Methods 108Interviews as Topic 106Surveys and Questionnaires 105Practice Guidelines as Topic 105Early Intervention, Educational 93Magnetic Resonance Spectroscopy 79Specimen Handling 78Radiosurgery 68Radiotherapy 54Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 34Resistance Training 33Therapeutics 32Surgical Procedures, Operative 31Drug Therapy 31Diet Therapy 30Behavior Therapy 29Counseling 28Proton Therapy 25Acupuncture Therapy 25Nutrition Assessment 24Exercise Test 24Magnetic Resonance Imaging 23Health Promotion 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Bendamustine Hydrochloride × 1 year × Clear all
NCT07126678 2025-08-17

Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
15 enrolled
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡